Rule caps off years-long advocacy effort from CAHC that included leading the successful fight to overturn past IRS policy penalizing HRA plans.
Draft bill comes after publication of CAHC drug pricing report recommending a budget neutral Part D out-of-pocket cap that does not raise premiums.
Draft bill reflects key CAHC recommendations for confronting surprise medical bills, spurring prescription drug competition, and addressing hospital monopolies.
Coalition highlights the potential of real-time benefit tools (RTBTs) in improving transparency and lowering costs.
Rule heeds coalition's call for expanded use of real-time benefit tools to help patients and providers identify cost-effective treatment options.
Coalition says draft bill puts “consumers first” by rejecting harmful binding arbitration policies but warns against reliance on state all-payer claims databases.